Precision Biosciences (DTIL) Enterprise Value Growth (5y) (2023 - 2026)

Precision Biosciences (DTIL) Enterprise Value Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Precision Biosciences 178.85 Mn 150.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 31.92%
Dec 31, 2025 -5.18%
Sep 30, 2025 15.50%
Jun 30, 2025 29.21%
Mar 31, 2025 12.92%
Dec 31, 2024 33.81%
Sep 30, 2024 13.27%
Jun 30, 2024 11.38%
Mar 31, 2024 -4.80%
Dec 31, 2023 -2.49%
Jun 30, 2023 -1.91%
Mar 31, 2023 -27.06%